The proteomic approach to urological biomarkers

BJU International

Volumn 94, Issue 9, 2004, Pages 1215-1216

  Kommu, Sashi ^a   Sharifi, Reza ^a   Eeles, Ros A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

BIOPSY; COMPUTER PROGRAM; DATA ANALYSIS; HUMAN; INFORMATION PROCESSING; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SEMINAL PLASMA; URINE;

BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; FORECASTING; HUMANS; PROTEOME; UROLOGIC DISEASES;

EID: 11144235939     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05323.x     Document Type: Note

References (10)

1. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of micromolecules. Rapid Commun Mass Spectrom 1993; 7: 576
2. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988; 60: 2299-301
3. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989; 246: 64-71
4. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21: 1164
5. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296
6. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572
7. Wright GL Jr, Cazares LH, Leung SM et al. Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 1999; 2: 264
8. Petricoin EF, Ornstein DK, Paweletz CP et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576-8
9. Ornstein DK, Rayford W, Fusaro VA et al. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 2004; 172: 1302-5
10. Kommu S, Sharifi R, Edwards S, Eeles R. Proteomics and urine analysis: a potential promising new tool in urology. BJU Int 2004; 93: 1172-3